Pharmaceutical Public Policy
Our rough guess is there are 126,000 words in this book.
At a pace averaging 250 words per minute, this book will take 8 hours and 24 minutes to read. With a half hour per day, this will take 17 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Publication
2016 - Taylor & Francis Group
Language
English
Word Count
126,000 words, Guess
Page Count
504 pages
Identifiers
- Open LibraryOL28809468M
- Internet Archivepharmaceuticalpu0000unse
- ISBN-139781498748506
- ISBN-101498748503
- Library of Congress Control Number2016427612
and 2 more
- OCLC Control Number930255403
- Better World Books9781498748506
Classifications
- LCCRA401.A3P54 2016
- LCCRA401.A3 P54 2016
Description
"Pharmaceutical Public Policy provides the understanding and framework required for effective organization, financing, and delivery of pharmaceutical products and services. It supplies an overview of the policy process as well as the roles of legislation and regulation in pharmaceutical policy.The book identifies the goals, objectives, and key policy issues of concern to stakeholders involved in the development of products, use of pharmaceuticals in healthcare, and administration of insurance programs by both the private and government sectors. Policy issues examined include the appropriateness of prescribing and patient adherence. Addressing questions of access, quality, and cost, the book considers the operation of the Affordable Care Act and Medicare Part D. It details the responsibilities of Federal providers of pharmaceutical care and private and public payers such as managed care organizations, pharmacy benefit managers, Medicare, and Medicaid. The book covers the policies and practices involved in promoting pharmaceutical products. It also considers pharmacoeconomics as a response to market failure. Finally, the book describes the market, the role of the manufacturer, drug shortages, and the responsibilities of the FDA. " -- Publisher's description.
Subjects
Topics
Other Editions
- Pharmaceutical Public Policy
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!